22q11.2缺失综合征及相关精神病的功能脑特征:基于深度神经网络的多队列研究
该研究纳入856名参与者(101例22q11.2DS、120例特发性早期精神病、101例特发性孤独症、123例特发性ADHD、411名健康对照),采用时空深度神经网络分析静息态fMRI数据。结果显示,该网络衍生的脑特征能以86-94%的准确率区分22q11.2DS与对照及22q11.2DS相关精神病,并在两个独立队列中无需额外训练即重复验证;关键特征位于突显网络前岛叶节点和多巴胺奖赏通路纹状体节点,且同样能区分特发性早期精神病与对照,但不能区分孤独症或ADHD。
要点
- stDNN脑特征区分22q11.2DS及相关精神病的准确率达86-94%,并在独立队列中重复验证。
- 关键区分特征位于突显网络前岛叶节点和多巴胺奖赏通路纹状体节点。
- 这些特征可区分特发性早期精神病与对照,但不区分孤独症或ADHD。
核心结论
- 22q11.2DS患者具有高度独特的功能脑组织模式,其相关精神病脑特征与特发性早期精神病在突显网络和多巴胺奖赏通路重叠。
研究设计与样本
- 病例对照设计,纳入856名参与者(101例22q11.2DS、120例特发性早期精神病、101例特发性孤独症、123例特发性ADHD、411名健康对照),获取多队列临床表型和任务态fMRI数据。
- 采用新型时空深度神经网络(stDNN)分析多队列数据,以识别22q11.2DS及相关精神病的功能脑特征。
- 使用stDNN检验22q11.2DS相关精神病脑特征与特发性早期精神病重叠、而与孤独症和ADHD不重叠的假设,并在主要队列和两个完全独立队列中验证。
主要发现
- stDNN衍生的脑特征在主要队列和两个完全独立队列中无需额外训练即以86-94%的准确率区分22q11.2DS与对照以及22q11.2DS相关精神病。
- 22q11.2DS相关精神病的稳健区分特征出现在突显网络前岛叶节点和多巴胺奖赏通路纹状体节点。
- 这些特征同样能区分特发性早期精神病个体与对照,但不能区分特发性孤独症或ADHD。
关键数值与推荐
- stDNN区分22q11.2DS与对照以及22q11.2DS相关精神病的准确率为86-94%,在主要队列和两个完全独立队列中均成立。
临床怎么用
- stDNN衍生的功能脑特征可作为区分22q11.2DS及相关精神病的潜在神经影像标志物,并在独立队列中无需额外训练即可重复验证。
- 突显网络前岛叶和多巴胺奖赏通路纹状体的特征重叠,为精神病异常突显理论模型提供了实证支持,并提示22q11.2DS可作为研究精神病神经生物学基础的遗传模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A major genetic risk factor for psychosis is 22q11.2 deletion (22q11.2DS). However, robust and replicable functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis remain elusive due to small sample sizes and a focus on small single-site cohorts. Here, we identify functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis, and their links with idiopathic early psychosis, using one of the largest multi-cohort data to date. We obtained multi-cohort clinical phenotypic and task-free fMRI data from 856 participants (101 22q11.2DS, 120 idiopathic early psychosis, 101 idiopathic autism, 123 idiopathic ADHD, and 411 healthy controls) in a case-control design. A novel spatiotemporal deep neural network (stDNN)-based analysis was applied to the multi-cohort data to identify functional brain signatures of 22q11.2DS and 22q11.2DS-associated psychosis. Next, stDNN was used to test the hypothesis that the functional brain signatures of 22q11.2DS-associated psychosis overlap with idiopathic early psychosis but not with autism and ADHD. stDNN-derived brain signatures distinguished 22q11.2DS from controls, and 22q11.2DS-associated psychosis with very high accuracies (86-94%) in the primary cohort and two fully independent cohorts without additional training. Robust distinguishing features of 22q11.2DS-associated psychosis emerged in the anterior insula node of the salience network and the striatum node of the dopaminergic reward pathway. These features also distinguished individuals with idiopathic early psychosis from controls, but not idiopathic autism or ADHD. Our results reveal that individuals with 22q11.2DS exhibit a highly distinct functional brain organization compared to controls. Additionally, the brain signatures of 22q11.2DS-associated psychosis overlap with those of idiopathic early psychosis in the salience network and dopaminergic reward pathway, providing substantial empirical support for the theoretical aberrant salience-based model of psychosis. Collectively, our findings, replicated across multiple independent cohorts, advance the understanding of 22q11.2DS and associated psychosis, underscoring the value of 22q11.2DS as a genetic model for probing the neurobiological underpinnings of psychosis and its progression.
引用
- Supekar K, de Los Angeles C, Ryali S, et al. Robust and replicable functional brain signatures of 22q11.2 deletion syndrome and associated psychosis: a deep neural network-based multi-cohort study. Mol Psychiatry. 2024. PMID: 38605171. doi:10.1038/s41380-024-02495-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。